Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Geisslinger

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Clinical and Experimental Immunology|January 19, 2019
Immunogenicity assay development and validation for biological therapy as exemplified by ustekinumabS Mojtahed Poor, T Ulshöfer, L A Gabriel, et al.
Drug Safety|February 15, 2000
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reportingH Dormann, U Muth-Selbach, S Krebs, et al.
European Journal of Pain (London, England)|June 16, 2016
Cleavage of SNAP-25 ameliorates cancer pain in a mouse model of melanomaK Olbrich, L Costard, C V Möser, et al.
Behavioural Brain Research|December 23, 2015
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitisN M W J de Bruin, K Schmitz, S Schiffmann, et al.
Clinical Immunology (Orlando, Fla.)|July 7, 2024
Metabolomic and lipidomic fingerprints in inflammatory skin diseases - Systemic illumination of atopic dermatitis, hidradenitis suppurativa and plaque psoriasisS Rischke, S M G Schäfer, A König, et al.
Clinical Pharmacology and Therapeutics|November 13, 2009
Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesiaB G Oertel, L Felden, P V Tran, et al.
British Journal of Clinical Pharmacology|May 21, 1999
Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signalsI Tegeder, M Levy, U Muth-Selbach, et al.
British Journal of Pharmacology|March 18, 2011
A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysmM Revermann, A Mieth, L Popescu, et al.
Acta Physiologica (Oxford, England)|April 29, 2016
PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cellsI Josipovic, C Fork, J Preussner, et al.
Acta Neuropathologica Communications|June 6, 2017
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitisK Schmitz, R Brunkhorst, N de Bruin, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Clinical and Experimental Immunology|January 19, 2019
Immunogenicity assay development and validation for biological therapy as exemplified by ustekinumabS Mojtahed Poor, T Ulshöfer, L A Gabriel, et al.
Drug Safety|February 15, 2000
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reportingH Dormann, U Muth-Selbach, S Krebs, et al.
European Journal of Pain (London, England)|June 16, 2016
Cleavage of SNAP-25 ameliorates cancer pain in a mouse model of melanomaK Olbrich, L Costard, C V Möser, et al.
Behavioural Brain Research|December 23, 2015
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitisN M W J de Bruin, K Schmitz, S Schiffmann, et al.
Clinical Immunology (Orlando, Fla.)|July 7, 2024
Metabolomic and lipidomic fingerprints in inflammatory skin diseases - Systemic illumination of atopic dermatitis, hidradenitis suppurativa and plaque psoriasisS Rischke, S M G Schäfer, A König, et al.
Clinical Pharmacology and Therapeutics|November 13, 2009
Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesiaB G Oertel, L Felden, P V Tran, et al.
British Journal of Clinical Pharmacology|May 21, 1999
Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signalsI Tegeder, M Levy, U Muth-Selbach, et al.
British Journal of Pharmacology|March 18, 2011
A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysmM Revermann, A Mieth, L Popescu, et al.
Acta Physiologica (Oxford, England)|April 29, 2016
PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cellsI Josipovic, C Fork, J Preussner, et al.
Acta Neuropathologica Communications|June 6, 2017
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitisK Schmitz, R Brunkhorst, N de Bruin, et al.
Pageof 19